i know! i'll go, meet him, chat informally and THEN ask if we can do a follow up on the record interview. and that either i would conduct it or someone else in our cfs community.
Since he was at the Prague conference with Dr. Mikovits, I'd like to get his opinion of the proceedings there re: German findings in CFS/ Mikovits' poster. Also the question was raised earlier about tissue biopsy -- other than the brain, which is dangerous to biopsy when people are alive, is there any thought about biopsying gut/ lymph node tissue (esp. people with recurrent enlarged lymph nodes?) as this is much less dangerous and more accessible? (Those monkey studies found XMRV in gut and lymph nodes primarily.)
Regarding the Canadian Consensus, since these have not been validated yet in a study, maybe he could suggest to researchers that they see which of their subjects match Canadian and whether these subjects are more likely to be XMRV+? They could still recruit people based on Fukuda to adhere to international definitions but many Canadian Consensus folks would also fall under Fukuda.